A Dutch approach to methicillin-resistant Staphylococcus aureus.
Verhoef
J
J
Beaujean
D
D
Blok
H
H
Baars
A
A
Meyler
A
A
van der Werken
C
C
Weersink
A
A
D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000331:legislation & jurisprudence; D005787:Gene Frequency; D017408:Guidelines as Topic; D006801:Humans; D008712:Methicillin / Q000494:pharmacology / Q000627:therapeutic use; D016106:Methicillin Resistance / Q000235:genetics; D009426:Netherlands / Q000453:epidemiology; D010406:Penicillins / Q000494:pharmacology / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000517:prevention & control*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000235:genetics
D010406:Penicillins; D008712:Methicillin